Literature DB >> 7195923

Cis-platinum associated hearing loss.

L P Rybak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7195923     DOI： 10.1017/s0022215100091374

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN： 0022-2151            Impact factor:   1.469


× No keyword cloud information.
  5 in total

Review 1.  Intracochlear drug delivery systems.

Authors:  Jeffrey T Borenstein
Journal:  Expert Opin Drug Deliv       Date:  2011-05-26       Impact factor: 6.648

2.  Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.

Authors:  Debashree Mukherjea; Sarvesh Jajoo; Tejbeer Kaur; Kelly E Sheehan; Vickram Ramkumar; Leonard P Rybak
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

Review 3.  Emerging Therapies for Sensorineural Hearing Loss.

Authors:  Matthew Gordon Crowson; Ronna Hertzano; Debara L Tucci
Journal:  Otol Neurotol       Date:  2017-07       Impact factor: 2.311

4.  Changes in the stria vascularis of the guinea pig due to cis-platinum.

Authors:  R A Tange; V D Vuzevski
Journal:  Arch Otorhinolaryngol       Date:  1984

5.  Functional mechanotransduction is required for cisplatin-induced hair cell death in the zebrafish lateral line.

Authors:  Andrew J Thomas; Dale W Hailey; Tamara M Stawicki; Patricia Wu; Allison B Coffin; Edwin W Rubel; David W Raible; Julian A Simon; Henry C Ou
Journal:  J Neurosci       Date:  2013-03-06       Impact factor: 6.167
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.